FGF-21 as a novel metabolic regulator
FGF-21 as a novel metabolic regulator
About this item
Full title
Author / Creator
Kharitonenkov, Alexei , Shiyanova, Tatiyana L. , Koester, Anja , Ford, Amy M. , Micanovic, Radmila , Galbreath, Elizabeth J. , Sandusky, George E. , Hammond, Lisa J. , Moyers, Julie S. , Owens, Rebecca A. , Gromada, Jesper , Brozinick, Joseph T. , Hawkins, Eric D. , Wroblewski, Victor J. , Li, De-Shan , Mehrbod, Farrokh , Jaskunas, S. Richard and Shanafelt, Armen B.
Publisher
United States: American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
Diabetes mellitus is a major health concern, affecting more than 5% of the population. Here we describe a potential novel therapeutic agent for this disease, FGF-21, which was discovered to be a potent regulator of glucose uptake in mouse 3T3-L1 and primary human adipocytes. FGF-21-transgenic mice were viable and resistant to diet-induced obesity....
Alternative Titles
Full title
FGF-21 as a novel metabolic regulator
Authors, Artists and Contributors
Author / Creator
Shiyanova, Tatiyana L.
Koester, Anja
Ford, Amy M.
Micanovic, Radmila
Galbreath, Elizabeth J.
Sandusky, George E.
Hammond, Lisa J.
Moyers, Julie S.
Owens, Rebecca A.
Gromada, Jesper
Brozinick, Joseph T.
Hawkins, Eric D.
Wroblewski, Victor J.
Li, De-Shan
Mehrbod, Farrokh
Jaskunas, S. Richard
Shanafelt, Armen B.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1088017
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1088017
Other Identifiers
ISSN
0021-9738
E-ISSN
1558-8238
DOI
10.1172/JCI23606
